# Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects

> **NCT01675024** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rotigotine, Period 1
- **DRUG:** Rotigotine, Period 2

## Key facts

- **NCT ID:** NCT01675024
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675024, "Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01675024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*